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Abstract 8 
The myosin-directed chaperone UNC-45B is essential for sarcomeric organization 9 
and muscle function from Caenorhabditis elegans to humans. The pathological 10 
impact of UNC-45B in muscle disease remained elusive. We report ten individuals 11 
with biallelic variants in the UNC45B gene, who exhibit childhood onset 12 
progressive muscle weakness. We identified a common UNC45B variant which acts 13 
as a complex hypomorph splice variant. Purified UNC-45B mutant proteins showed 14 
changes in folding and solubility. In situ localization studies further demonstrated 15 
reduced expression of mutant UNC-45B in muscle combined with abnormal 16 
localization away from the A-band towards the Z-disk of the sarcomere. The 17 
physiological relevance of these observation was investigated in C. elegans by 18 
transgenic expression of conserved UNC-45 missense variants, which showed 19 
impaired myosin binding and defective muscle function for one. Together, our 20 
results demonstrate that UNC-45B impairment manifests as a chaperonopathy with 21 
progressive muscle pathology, which discovers the previously unknown, 22 
conserved role  of UNC-45B in myofibrillar organization.  23 
 4 
Introduction 1 
Muscle development and function require a complex system of structural and motor 2 
proteins organized into contractile units referred to as sarcomeres. The sarcomeric repeat 3 
is a supra-molecular dynamic structure, in which actin and myosin filaments, together with 4 
associated proteins, are arranged in a precise order. The near crystalline lattice of the 5 
sarcomere coordinates actin-myosin cross bridge cycling, which facilitates sarcomere 6 
shortening, filament gliding, and muscle contraction. The folding, stability, and 7 
organization of sarcomeric proteins into muscle filaments is governed by molecular 8 
chaperones1. The fundamental importance of chaperones for the development and 9 
maintenance of skeletal muscle is underscored by recent studies indicating that 10 
chaperone dysfunction is responsible for a distinct subset of hereditary myopathies. 11 
These so called chaperonopathies are characterized by pathogenic variants in genes 12 
encoding chaperones and co-chaperones of structural muscle components. For example, 13 
loss of the small heat shock protein CRYAB (MIM: 123590) affects folding of the muscle 14 
intermediate filament desmin, clinically manifesting as a myofibrillar myopathy known as 15 
αB‐crystallinopathy2. Additional disease mechanisms include impaired homeostasis of 16 
chaperone‐assisted selective autophagy (CASA) linked to pathogenic variants in the 17 
HSP70 co-chaperone BAG3 (MIM: 603883), clinically manifesting with a progressive 18 
myofibrillar myopathy with significant cardiac as well as peripheral nerve pathologies3; 4. 19 
The subsequent identification of variants in DNAJB6 (MIM: 611332) causing limb-girdle 20 
muscular dystrophy (LGMDD1) provided clear evidence of abnormal sacromeric 21 
aggregate pathology in these chaperonopathies5; 6. The clinical spectrum of 22 
chaperonopathies has expanded over the last years to include hereditary motor 23 
 5 
neuropathies with or without muscle involvement, caused by HSPB1 (MIM: 602195), 1 
HSPB3 (MIM: 604624), HSPB8 (MIM: 608014), and DNAJB2 (MIM: 604139) gene 2 
defects7. These examples suggest that abnormal chaperone function is an important 3 
driver in neuromuscular disease, suggesting that its correction might be a valid 4 
therapeutic approach8. 5 
The abovementioned chaperones are involved in the proper folding and stability of 6 
aggregation prone proteins in various cell types including muscle. In contrast to the broad 7 
functional spectrum of many molecular chaperones, more specialized chaperone 8 
systems exist which regulate muscle contraction by folding and assembly of conventional 9 
type II myosin9. Type II myosins are composed of two myosin heavy chains each 10 
containing an identical myosin head, whose folding requires precise temporal and spatial 11 
control, mediated by conserved UCS (UNC-45/CRO1/She4p) domain containing 12 
proteins10-12. As one founding member of the UCS family, UNC-45 (MIM: 611220) was 13 
first identified in C. elegans revealing that conditional loss-of-function mutations result in 14 
abnormal myofilament assembly and uncoordinated locomotion defects13. UNC-45 15 
homologs exist in all vertebrates, and various point mutations have been associated with 16 
skeletal and cardiac function in C. elegans, Drosophila, zebrafish, and Xenopus14; 15. 17 
UNC-45 contains four domains: an N-terminal TPR domain (TPR repeat 1–3), a 18 
conserved central domain (ARM repeat 4–5), a neck domain (ARM repeat 6–9), and a C-19 
terminal UCS domain (ARM repeat 10–17) (Figure 1A)16; 17. The N-terminal TPR domain 20 
is important for binding to the chaperones Hsp70 and Hsp90, while the C-terminal UCS 21 
domain associates with the head of muscle myosin18. Mechanistically, UNC-45 oligomers 22 
have been described to serve as a multisite-docking platform, which supports precisely 23 
 6 
defined collaboration with the general chaperones Hsp70 and Hsp90 in folding and 1 
assembly of myosin filaments17. Thus, UNC-45 provides substrate specificity for the 2 
partner chaperones during late stages of myofibrillogenesis (Figure 1B). The repetitive 3 
arrangement of UNC-45 oligomers with myosin binding UCS domains protruding from the 4 
linear protein chain serves as template that defines the periodicity of myosin organization 5 
in growing sarcomeres. 6 
The muscle sarcomere is a complex structure permanently challenged by 7 
mechanical stress, which presupposes the dynamic coordination between protein folding 8 
and degradation pathways1; 18. Based on its central role as myosin-directed chaperone, 9 
both UNC-45 stability and localization are precisely regulated. UNC-45 protein 10 
degradation is mediated by ubiquitin-dependent proteolysis, which coordinates myosin 11 
folding and assembly both in C. elegans and human myoblasts18; 19. Conclusively, 12 
defective degradation of UNC-45B in individuals with VCP-related inclusion-body 13 
myopathy (MIM: 601023) is linked to disorganized myofibrils and impaired sarcomeric 14 
function19.  15 
Despite the conserved role in myofibrillogenesis and evidence from multiple model 16 
organisms, the relevance of muscle-specific UNC-45B dysfunction for the pathology and 17 
pathogenesis of human myopathies had remained unclear19. Here we present 18 
comprehensive findings that establish biallelic pathogenic variants in UNC45B  (MIM: 19 
611220) as a novel chaperonopathy, clinically manifesting as a progressive myopathy 20 
with recognizable muscle eccentric core histology in humans. 21 
Material & Methods 22 
Recruitment and sample collection  23 
 7 
Individuals were identified through their local neurology and genetics clinics. P3 and P4 1 
were identified through GeneMatcher20. Written informed consent and age-appropriate 2 
assent for study procedures were obtained by a qualified investigator [protocol 12-N-3 
0095 approved by the National Institute of Neurological Disorders and Stroke, National 4 
Institutes of Health Institutional Review Board (IRB); Project ID: 07/N018, Research 5 
Ethics Committee (REC) Ref: 07/Q0512/26 approved by the UCLH local institutional IRB; 6 
Protocol 317-05 approved by the Regional Ethical Review Board in Gothenburg (317-7 
05)]. Medical history was obtained and clinical evaluations, including muscle MRI and 8 
muscle biopsy, were performed as part of the standard diagnostic examination. Muscle 9 
MRI included T1 axial images of the lower extremities. Muscle biopsy histology slides 10 
and electron microscopy images (EM) were independently reviewed. DNA and muscle 11 
biopsy samples were obtained according to standard procedures. 12 
 13 
Whole Exome and RNA Sequencing  14 
Whole exome sequencing (WES) was pursued by six independent teams, details are 15 
provided in supplemental methods. Confirmation of individuals’ variants and available 16 
family members was performed by Sanger sequencing. RNA sequencing on RNA 17 
extracted from muscle was pursued for P2, P3, and P4 muscle, details can be found in 18 
supplemental methods.  19 
 20 
Western blot 21 
Skeletal muscle biopsy sections from a normal control and affected individuals P1, P2, 22 
P9, and P10 were homogenized using lysis buffer contain 4 % SDS, 125 mM Tris-HCL 23 
 8 
(pH 8.8), 40% Glycerol, 500 µM PMSF and 100 mM DTT. The lysates were sonicated on 1 
ice followed by centrifugation (14000 rpm for 15 minutes at 4°C). The protein from the 2 
supernatants was electrophoresed on NuPAGE 4–12% Bis-Tris gel (Invitrogen, Carlsbad, 3 
CA) under reducing condition followed by a transferring to nitrocellulose membrane 4 
(Millipore, Billerica, MA). After block with Odyssey PBS blocking buffer (LI-COR, Lincoln, 5 
NE), the membrane was incubated with primary antibody anti-UNC-45B (Sigma-Aldrich, 6 
St. Louis, MO), anti-desmin (Sigma-Aldrich, St. Louis, MO) overnight at 4°C and 7 
subsequently incubated with IRDye@ 680RD Goat anti-Rabbit IgG and IRDye@ 800CW 8 
Goat anti-Mouse IgG secondary antibodies (LI-COR, Lincoln, NE) at room temperature 9 
and imaged on the Odyssey CLx Imaging System (LI-COR, Lincoln, NE).  10 
 11 
Immunostaining & microscopy 12 
Pre-cooled 100% methanol fixed 8 µm muscle longitudinal sections were blocked in PBS 13 
with 10% goat serum and 0.1% Triton X-100, then incubated with primary antibodies anti-14 
UNC-45B (Sigma-Aldrich, St. Louis, MO) and anti-myomesin (DSHB, Iowa City, IA) 15 
overnight at 4°C. The antibody labeling was detected with secondary antibodies 16 
Alexa488-conjugated goat anti-mouse IgG and Alexa568-conjugated goat anti-rabbit IgG 17 
(Thermo Fisher Scientific, Waltham, MA) for 1 h at room temperature. Prepared muscle 18 
sections were imaged with a Zeiss Airy microscope (Zeiss, Germany). Images were 19 
analyzed using ImageJ software (National Institutes of Health). 20 
 21 
Human UNC-45B protein structure modelling and PyMOL structural analysis 22 
 9 
For human UNC-45B protein structure modelling, the SWISS-MODEL online tool was 1 
used21. C. elegans UNC-45 (PDB: 4i2z) was indicated as reference crystal structure. For 2 
further structural analyses the PyMOL 2.3.3 software (Schrödinger) and proprietary 3 
scripts were used. The modelled human UNC-45B protein structure was displayed and 4 
single amino acid mutations inserted using the mutagenesis wizard tool choosing the 5 
rotamer with the lowest root-mean-square deviation value. Steric and electrostatic 6 
interactions were depicted using the show_bumps plugin and calculations of van der 7 
Waals overlaps. 8 
 9 
Cloning, protein expression, and purification 10 
Standard molecular biology protocols were used22. Human UNC-45B cDNA was cloned 11 
into the E. coli expression vector pET21a with an N-terminal myc-tag and a C-terminal 12 
6xHIS-tag using the NEBuilder Master Mix (New England Biolabs). The vector was 13 
mutated using the Q5 Site-Directed Mutagenesis Kit (New England Biolabs) to introduce 14 
the following mutations: Arg754Gln, Arg778Trp, Ser403Pro, and Cys514Arg. A pET21a 15 
vector encoding myc-UNC-45-6xHIS amplified from C. elegans cDNA was mutated using 16 
the Q5 Site-Directed Mutagenesis Kit (New England Biolabs) to introduce the following 17 
mutations: Arg767Gln and Arg792Trp. Oligonucleotides used in this study are listed in 18 
Table S2. Overexpression in E. coli BL21-CP was induced with 100 µM IPTG and carried 19 
out at 16–18°C for 18–20 h. Subsequently, cells were harvested by centrifugation and 20 
lysed by sonication in 50 mM NaH2PO4 (pH 8.0), 300 mM NaCl, 10 mM imidazole. The 21 
tagged proteins were affinity purified by submitting the cleared bacterial lysates to Ni-NTA 22 
agarose-binding (QIAGEN) according to the manufacturer’s instructions. After 23 
 10 
exchanging the buffer to 20 mM Tris (pH 8.0), 150 mM NaCl, protein amount was 1 
determined by Coomassie staining of SDS-PAGE gels with bovine serum albumin as 2 
standard. 3 
 4 
Partial trypsin proteolysis 5 
For limited proteolysis assays, 2.4 µg purified proteins myc-UNC-45B(WT)-6xHIS, myc-6 
UNC-45B(Arg754Gln)-6xHIS, myc-UNC-45B(Arg778Trp)-6xHIS, myc-UNC-7 
45B(Ser403Pro)-6xHIS, myc-UNC-45B(Cys514Arg)-6xHIS, myc-UNC-45-6xHIS, myc-8 
UNC-45(Arg767Gln)-6xHIS and myc-UNC-45(Arg792Trp)-6xHIS, diluted in PBS (pH 7.4) 9 
were incubated with 20 ng of trypsin (SERVA) for 1, 2, 5, 10, 20, 40, or 60 min at room 10 
temperature (~22°C) or 37°C. A control reaction was incubated with PBS instead of 11 
trypsin for 60 min (time point 0). Reactions were stopped by adding 5x SDS sample buffer 12 
(0.25 M Tris-HCl, 10% SDS, 50% glycerol, 0.5 M DTT, 0.25% bromophenol blue) and 13 
flash freezing in liquid nitrogen. After collecting, all samples were boiled at 95°C for 5 min, 14 
run on SDS-PAGE gels and stained with Instant Blue Coomassie stain (Expedeon). 15 
Images were taken with an Odyssey CLx Imager (LI-COR Biotechnology) using the 700 16 
nm channel, intact protein bands were quantified using Image Studio Version 5.2 software 17 
and relative fluorescence signal compared to time point 0 was plotted. 18 
 19 
Thermal shift assay with SYPRO Orange 20 
10 µg purified proteins myc-UNC-45B(WT)-6xHIS, myc-UNC-45B(Arg754Gln)-6xHIS, 21 
myc-UNC-45B(Arg778Trp)-6xHIS, myc-UNC-45B(Ser403Pro)-6xHIS, myc-UNC-22 
45B(Cys514Arg)-6xHIS were diluted in ice-cold 20 mM Tris (pH 8.0), 150 mM NaCl, and 23 
 11 
2.5x SYPRO Orange protein stain and heated in 0.5° increments from 10°C to 95°C in a 1 
CFX Real-Time PCR Cycler (Bio-Rad). Melt curves were recorded using the FRET 2 
channel, normalized to buffer-only control and fitted to Boltzmann sigmoidal curve 3 
regression in GraphPad Prism 5 software. Half maximal temperatures were read as 4 
melting temperatures. 5 
 6 
Filter trap assay and slot blot 7 
20 µg purified proteins myc-UNC-45B(WT)-6xHIS, myc-UNC-45B(Arg754Gln)-6xHIS, 8 
myc-UNC-45B(Arg778Trp)-6xHIS, myc-UNC-45B(Ser403Pro)-6xHIS, myc-UNC-9 
45B(Cys514Arg)-6xHIS were diluted in ice-cold 20 mM Tris (pH 8.0), 150 mM NaCl and 10 
incubated rotating at room temperature (22°C) for 1 h. Three decreasing amounts of 11 
protein solution were loaded onto a 0.2 µm cellulose acetate membrane assembled in a 12 
slot blot apparatus (Bio-Rad). The membrane was washed with PBS, 0.2% SDS and 13 
retained aggregated protein was assessed by immunoblotting for myc-tag (9E10, Roche). 14 
 15 
C. elegans maintenance and transgenic lines 16 
Unless stated otherwise, nematodes were grown at 15°C on nematode growth medium 17 
(NGM) plates seeded with the bacterial E. coli strain OP50 as a food source according to 18 
standard protocols and methods23; 24. The N2 Bristol strain served as wild-type. Additional 19 
strains used in this study are unc-119(ed4)III, unc-45(m94)III, and unc-45(m94)III; 20 
hhIs84[unc-119(+); unc-54::unc-45FLAG]17. For the generation of transgenic rescue 21 
strains, plasmids encoding C-terminally FLAG-tagged UNC-45 under the muscle-specific 22 
promoter unc-54, containing the unc-119(+) selection marker, generated in reference17 23 
 12 
were mutated using the Q5 Site-Directed Mutagenesis Kit (New England Biolabs). The 1 
following conserved mutations were introduced: Arg767Gln, Arg792Trp, Ile422Pro, and 2 
Cys523Arg. Oligonucleotides used in this study are listed in Table S2. These constructs 3 
were bombarded into unc-119(ed4) worms as described previously25. Microparticle 4 
bombardment was done with the Bio-Rad Biolistic PDS-1000/HE with ¼” gap distance, 9 5 
mm macrocarrier to screen distance, 28 inches of Hg vacuum and a 1350 psi rupture 6 
disc. Per bombardment, about 1 mg of 1 μm microcarrier gold beads were coated with 8-7 
10 μg linearized DNA. Animals were allowed to recover for 1 h at room temperature and 8 
were then transferred to 90 mm NGM plates seeded with E. coli OP50 bacteria. After 3 9 
weeks at 25°C, motile non-unc worms were singled and screened for homozygosity. All 10 
strains that were used in this study are listed in Table S3. 11 
 12 
Motility assay 13 
For body bend assays, individual young adult worms grown at 25°C were placed in 1 ml 14 
M9 buffer (room temperature 22°C), body bends were counted during 30 s, and doubled 15 
to calculate body bend counts per minute. 16 
 17 
Quantification of I-Bands assembly 18 
Sarcomere assembly was monitored by labeling F-actin with phalloidin-rhodamine 19 
(Invitrogen). Briefly, synchronized young adult worms were fixed in 4% (w/v) 20 
paraformaldehyde solution for 20 min at room temperature. After permeabilization of the 21 
cuticle in a 3% β-mercaptoethanol solution containing 1% Triton X-100, the F-actin in 22 
body wall muscle sarcomeres was stained with phalloidin-rhodamine (Invitrogen). Stained 23 
 13 
worms were mounted on glass slides and imaged using an Axio Imager.Z1 microscope 1 
(Zeiss). The number of I-bands per body wall muscle cell was counted in the same area 2 
(between pharynx and vulva). 3 
 4 
Co-immunoprecipitation studies 5 
For co-immunoprecipitations, synchronized young adult wild-type worms, unc-45(m94), 6 
or worms expressing transgenic, FLAG-tagged UNC-45 were sonicated in lysis buffer (50 7 
mM Tris (pH 8.0), 150 mM NaCl, 1% Triton X-100, and protease inhibitor mix (Roche)), 8 
and immunoprecipitation was performed using the μMACS DYKDDDDK Isolation Kit 9 
(Miltenyi Biotec) following the manufacturer’s instructions. Briefly, 150 µg of worm lysates 10 
were incubated with 50 µl Anti-DYKDDDDK MicroBeads for 45 min at 4°C. 11 
Immunoprecipitants were washed four times with 200 µl Wash Buffer 1 (150 mM NaCl, 12 
1% Igepal CA-630 (formerly NP-40), 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris 13 
HCl (pH 8.0)) on μColumns placed in the magnetic field of a μMACS Separator. 14 
Subsequently, immunoprecipitants were washed once in 100 µl Wash Buffer 2 (20 mM 15 
Tris HCl (pH 7.5)) and eluted with hot 2x SDS-PAGE sample buffer. Western blotting was 16 
performed using antibodies against UNC-45, DAF-21 (gift from Richard Morimoto), UNC-17 
54 (mAb5-8-1, DSHB) and Tubulin (T6074, Sigma). Proteins were detected by 18 
immunoblotting on PVDF membranes using Amersham ECL Prime (GE Healthcare) in a 19 
Bio-Rad ChemiDoc Imager. 20 
 21 
Statistical analysis 22 
 14 
For statistical analyses the GraphPad Prism 5 software was used. Non-parametric 1 
statistical tests were used according to the software’s recommendations and specified in 2 
the respective figure legends and descriptive text. Results are usually given as mean and 3 
standard error of the mean (SEM). 4 
 5 
Results 6 
Biallelic variants in the myosin chaperone UNC-45B in individuals with muscle 7 
weakness. We report ten affected individuals from eight independent families clinically 8 
manifesting with childhood onset, progressive proximal and axial muscle weakness and 9 
various degrees of respiratory insufficiency. The clinical presentations are summarized in 10 
Table 1. Of the identified families, there was one family with three affected siblings (P6, 11 
P7, P8). The only other notable family history was for P1 who had a brother with a history 12 
of nystagmus and vomiting, who was suspected to have a mitochondrial disorder of 13 
unknown genetic etiology and who passed away at 3 months of age.  14 
To elucidate the possible origin of the muscle disease, whole exome sequencing 15 
(WES) was pursued, identifying a recurring homozygous c.2261G>A; p.(Arg754Gln) 16 
missense variant in UNC45B (NM_173167.3) in seven affected individuals from five 17 
independent families of various ethnic backgrounds (Table S1). This variant is rare with 18 
nine reports in heterozygous state, and none in homozygosity, in the Genome 19 
Aggregation Database (gnomAD) with an allele frequency of 4.732 × 10−5. On the protein 20 
level, this variant impacts a conserved Arginine in the UNC-45 C-terminal UCS domain, 21 
which is essential for the interaction with myosin (Figure 1A). P2 was found to be 22 
compound heterozygous for a maternally inherited c.2261+5G>C splice variant and a 23 
 15 
paternally inherited c.2332C>T; p.(Arg778Trp) missense variant impacting the UCS 1 
domain of UNC-45B. This rare missense variant is predicted to be damaging and reported 2 
45 times in heterozygous state, and none in homozygosity, in gnomAD with an allele 3 
frequency of 1.593× 10−4. P9 was found to have the recurring p.(Arg754Gln) variant in 4 
compound heterozygosity with a rare predicted to be damaging c.1207T>C; 5 
p.(Ser403Pro) variant impacting the UNC-45B neck domain (Figure 1A). Lastly, P10 was 6 
found to be homozygous for a predicted to be damaging c.1540T>C; p.(Cys514Arg) 7 
missense variant impacting the UNC-45B neck domain. This variant is listed as a rare 8 
SNP (rs775340790) with nine reported in heterozygous state, and none in homozygosity, 9 
in gnomAD with an allele frequency of 3.580 × 10−5.  10 
 11 
UNC45B variants manifest clinically as a childhood onset myopathy. Six individuals 12 
presented with first recognition of axial and proximal weakness in early childhood. These 13 
affected individuals reported slow progression of muscle weakness but remained 14 
ambulatory into adulthood. Of interest, these individuals were all homozygous for the 15 
recurring c.2261G>A; p.(Arg754Gln) variant. Three individuals with other UNC45B 16 
variants were reported to have a congenital onset of symptoms.   17 
Serum creatine kinase (CK) levels were reported within normal reference ranges 18 
in all individuals. Respiratory function ranged from significantly decreased to normal with 19 
forced vital capacity (FVC) measurements ranging from 45-99% predicted. Five 20 
individuals had abnormalities on ECG, while structural cardiac abnormalities were seen 21 
in two. Lower extremity muscle MR imaging was available for five individuals (Figure 2A), 22 
 16 
which revealed evidence of mild fat infiltration of most muscles resulting in a marbled-like 1 
appearance but without an emerging clear pattern of muscle involvement.  2 
 3 
UNC45B-related myopathy manifests histologically with eccentric cores. 4 
Histological analysis of the muscle biopsies was performed in seven individuals (Figure 5 
2B–K). Hematoxylin and eosin (H&E) stain showed variation in fiber size with internalized 6 
nuclei, resulting in multinucleated fibers in five individuals (Figure 2B). On Gömöri 7 
Trichrome (GT) stain, a few fibers had evidence of uneven aspect with deposit of 8 
fuchsinophilic material in three biopsies (Figure 2C), and there was evidence of apparent 9 
cytoplasmic bodies as well as rimmed vacuoles in one. On oxidative staining with succinic 10 
dehydrogenase (SDH), nicotinamide adenine dinucleotide (NADH), and cytochrome 11 
oxidase (COX), large irregular areas of oxidative defects were identified in numerous 12 
muscle fibers. In particular, in five of the seven biopsies reviewed SDH staining and COX 13 
staining revealed more defined areas of reduced oxidative activity with core-like regions 14 
often located along the periphery of fibers, consistent with eccentric cores (Figure 2D and 15 
F). In contrast, in two biopsies there were areas of reduced NADH staining alternating 16 
with areas of increased staining along the periphery of fibers. On ATPase stains, there 17 
was evidence of type I fiber predominance and areas of absence/reduction of ATPase 18 
activity, particularly in the periphery of fibers, corresponding to the areas resembling 19 
eccentric cores on the oxidative stains (Figure 2E). Electron microscopy (EM) was 20 
performed in four individuals (Figure 2G–K). In longitudinal sections, there were large 21 
areas of myofibrillar disorganization that extended the entire width of the fiber which 22 
appear devoid of mitochondria, thus resembling unstructured cores. In transverse 23 
 17 
sections, well-demarcated unstructured cores were seen in subsarcolemmal regions. In 1 
addition, wide dark bands of diffused Z-line derived material were observed and are 2 
reminiscent of myofibrillar material. More rarely, cytoplasmic bodies (Figure 2K) and rod-3 
like inclusions were seen, and autophagy material was observed in some fibers.   4 
 5 
Fiber contractile function is normal in P1 UNC-45B muscle. Muscle contraction is 6 
affected by the cyclic interaction between the myosin cross-bridges and actin as an 7 
adenosine triphosphate (ATP) hydrolysis dependent process26. The maximum force that 8 
a muscle fiber can generate is dependent on the rate of myosin cross bridge cycling 9 
kinetics. To evaluate whether force generation in UNC-45B  muscle was impaired in this 10 
assay, we compared the mechanics of permeabilized single muscle fibers from P1 11 
(homozygous c.2261G>A) to controls. Rate of tension redevelopment (Ktr) was used as 12 
a parameter reflecting the rate of both cross-bridge attachment and reattachment, while 13 
tension cost reflects the rate of myosin cross bridge detachment from actin determined 14 
by measuring the ATP utilization during force generation. P1 muscle expressed 15 
predominately myosin heavy chain (MHC) type I fibers. Contractile properties depend on 16 
MHC composition, and therefore, we compared contractile data to controls in whom MHC 17 
type I and type II fibers were separated out. Our data showed normal fiber contractile 18 
performance, with no difference in maximal tension generated by UNC-45B fibers 19 
compared to controls (Figure S1A). The calcium sensitivity of force, the 20 
Ca2+ concentration needed for 50% of maximal force generation, was also normal in P1 21 
muscle compared to control (Figure S1B). Overall, single fiber mechanics in P1 muscle 22 
 18 
tissue showed normal cross-bridge cycling kinetics, with normal tension costs compared 1 
to control (Figure S1C and D).  2 
 3 
UNC-45B protein is mislocalized in UNC-45B muscle. Immunofluorescence 4 
localization studies were performed using myomesin, a major structural protein of the M-5 
line, and α-actinin, a Z-line protein, as markers27. Whereas in control muscle UNC-45B 6 
protein was localizing to the A-band around the M-line as expected, in affected individuals 7 
there appears to be a loss of the residual UNC-45B protein at the M-line, suggestive of 8 
mislocalization away from the A-band to the Z-disk (Figure 3A and B). Specificity of the 9 
UNC-45B antibody was confirmed in control muscle (Figure S2).  10 
 11 
The recurring UNC45B c.2261G>A variant acts as a complex hypomorph splice 12 
variant. UNC45B appears to be intolerant to complete biallelic loss of function, which is 13 
in accordance with the essential role of UNC-45 in C. elegans28-30. Therefore, we did not 14 
observe individuals with biallelic null variants, and no homozygous null variants are listed 15 
in gnomAD31. Haploinsufficiency of UNC45B, however, does not appear to cause a 16 
severe or early myopathy, as individuals heterozygous for a loss of function UNC45B 17 
variant are reported in gnomAD. The recurring c.2261G>A UNC45B variant affects the 18 
last base pair (G) of exon 17 and is adjacent to the splice donor site thus potentially 19 
interfering with  normal splicing (Figure 4A)32; 33. To investigate this possibility, muscle 20 
RNA sequencing, available for two individuals (P3 and P4, both homozygous for the 21 
c.2261G>A UNC45B variant) was analyzed (Figure S3A). This transcript analysis 22 
revealed a five-fold reduction of UNC45B transcripts compared to controls and 23 
 19 
furthermore indicated that two detectable UNC45B splice products were generated from 1 
the mutant allele (Figure S3B). The first detectable transcript encodes the full-length 2 
protein containing the Arg754Gln missense variant. The second transcript results from 3 
altered splicing due to interruption of the normal splice donor and subsequent activation 4 
of a nearby intronic cryptic splice donor site c.2261+10 (Figure 4B). The resulting splice 5 
product extends exon 17 into the intron, causing the inclusion of an in-frame STOP codon. 6 
This nonsense transcript is unstable and most likely subject to nonsense-mediated decay. 7 
A low level of the elongated nonsense transcript escaped mRNA decay and was therefore 8 
detectable on muscle RNA sequencing. From this we conclude that the c.2261G>A 9 
UNC45B variant results in a hypomorphic splice variant. The effect is a situation in which 10 
the majority of transcript is mis-spliced to include a premature termination codon with 11 
predominant degradation before translation occurs, while any residual correctly spliced 12 
full-length transcript will result in a protein containing the Arg754Gln missense variant.   13 
RNA sequencing and reverse transcription of mRNA with subsequent cDNA 14 
sequencing in P2 muscle extracts revealed allelic imbalance towards the p.(Arg778Trp) 15 
variant, while the c.2261+5G>C splice variant resulted in activation of the same nearby 16 
intronic cryptic donor site as seen for the c.2261G>A variant, and is thus expected to lead 17 
to the same nonsense mediated decay (Figure S3C–H). In summary, the c.2261G>A and 18 
the c.2261+5G>C UNC45B variants both impact the proper splicing of the mRNA and 19 
thus the stability of the UNC45B mRNA. 20 
To investigate the impact of the UNC45B variants on the protein level, we 21 
performed western blot on muscle extracts from P1, P2, P9, and P10. All four individuals 22 
 20 
showed a significant reduction of UNC-45B total protein compared to controls (Figure 1 
4C). 2 
 3 
Missense variants impact conserved UNC-45B domains. The UNC-45B amino acid 4 
sequence is highly conserved down to invertebrates, which allowed us to explore 5 
structural impacts of variants on basis of the recently elucidated structure of C. elegans 6 
UNC-4514; 16; 17. Both arginine residues mutated in our cohort (Arg754 and Arg778) are 7 
part of helices 1 and 3, respectively, in the armadillo (ARM) repeat 14 (Figure 5A). ARM 8 
14 is located in the hinge region, which connects the C-terminal half of the UCS domain 9 
(ARM repeats 14–17) with the N-terminal half (ARM repeats 10–13) forming part of the 10 
myosin-binding canyon. Exchanging Arg754 for a glutamine does not seem to drastically 11 
interfere with the surrounding structures according to PyMOL calculations of van der 12 
Waals overlaps. Conversely, exchanging the positively charged Arg778 for a bulky 13 
hydrophobic tryptophan would most probably sterically interfere with its surroundings, up 14 
to the possible shifting of the overall structure of the UCS domain. P9 was found to carry 15 
the recurring p.(Arg754Gln) missense in compound heterozygosity with a p.(Ser403Pro) 16 
missense located in the UNC-45 neck domain. Ser403 is conserved in zebrafish UNC-17 
45B but position 403 appears to have a broader tolerance for other amino acids featuring 18 
a threonine in Drosophila and an isoleucine in C. elegans UNC-45. Its functional 19 
importance therefore may be restricted to vertebrates but needs to be investigated further. 20 
Close cooperation of the chaperones Hsp90 and Hsp70 with UNC-45 allows for 21 
the precise temporal and spatial control of the incorporation of myosin into contractile 22 
muscle thick filaments1; 17; 34. P10 was found to be homozygous for a p.(Cys514Arg) 23 
 21 
missense variant, which impacts the neck domain, and is therefore the only individual in 1 
this series without an UNC-45 UCS domain allele. Given that the UNC-45 neck domain 2 
confers flexibility and allows exact positioning of the UCS and the TPR domains to one 3 
another, structural interference in this region is likely to impact protein function. The 4 
affected cysteine residue is buried in the inner structure of ARM 9 in the neck domain of 5 
UNC-45. Exchanging a cysteine for a positively charged arginine would most probably 6 
lead to steric hindrance and electrostatic interference within the protein structure (Figure 7 
5A). 8 
 9 
Recombinant UNC-45B protein variants are prone to aggregation. To further 10 
elucidate structural impacts of the UNC45B variants, we recombinantly expressed the 11 
UNC-45B mutant proteins in E. coli and subjected them to time-dependent partial trypsin 12 
proteolysis experiments at room temperature (22°C). All mutant variants seemed to be 13 
less susceptible to proteolysis than the wild-type with the p.(Ser403Pro) variant showing 14 
the most pronounced difference (Figure S4A and B). Repeating the partial trypsin 15 
proteolysis assay at the physiological temperature 37°C corroborated the result that 16 
trypsin proteolysis was delayed in the mutant variants with the p.(Ser403Pro) variant 17 
being significantly different in non-parametric Friedman test (Figure 5B and C, Table S4). 18 
In addition, we performed thermal shift assays (TSA) using the protein stain SYPRO 19 
Orange to determine melting temperatures of the recombinant proteins in solution. The 20 
stain intercalates with gradually exposed hydrophobic residues on the protein's surface 21 
allowing for melting temperature estimation based on the half-maximal SYPRO 22 
fluorescence in a Boltzmann approximation. The assay revealed that all variant proteins 23 
 22 
have a lower melting temperature (Arg754Gln: 38.18±0.05145°C, Arg778Trp: 1 
37.85±0.04907°C, Ser403Pro: 37.88±0.1241°C, Cys514Arg: 36.90±0.03901°C) 2 
compared to wild-type (43.16±0.04358°C) in the Tris-based buffer (Figure 5D, Tables S5 3 
and S6). Exposed hydrophobic residues at a lower temperature might suggest 4 
aggregation tendency. On these grounds, we subjected the recombinant mutant variants 5 
to a filter trap assay to search for aggregates after incubation at room temperature (22°C). 6 
A subsequent slot blot confirmed the suspected higher aggregation of the mutant variants 7 
compared to the wild-type to a similar degree as the absolute SYPRO fluorescence at 8 
22°C indicated (Figure 5E and F). Further increased aggregation propensity of the mutant 9 
variants around the melting temperature of 37°C could also explain the observed delay in 10 
in vitro proteolysis due to a fraction of the substrate being sequestered in trypsin-11 
inaccessible aggregates. Together, biochemical analyses of the recombinant UNC-45B 12 
mutant variants suggest that amino acid substitutions at the here reported positions will 13 
likely lead to structural changes in the UNC-45B protein.  14 
 15 
Myopathy-related UNC-45B mutant missense proteins cannot rescue a conditional 16 
loss-of-function allele. To test for the functional performance of the disease associated 17 
UNC-45B UCS variant proteins in myosin assembly, we made use of an in vivo rescue 18 
approach in C. elegans described previously17. Temperature-sensitive (ts) unc-45(m94) 19 
mutant worms exhibit a severe movement defect and disarrangement of the otherwise 20 
highly conserved sarcomere organization when grown at the non-permissive temperature 21 
of 25°C34. By expressing the corresponding C. elegans UNC-45 variants in conditional 22 
loss-of-function worms, we were able to analyze to what degree muscle function of the 23 
 23 
unc-45 ts mutant could be restored. When transferred to liquid medium, worms swim by 1 
thrashing their bodies sideways. This agile movement is almost completely abolished in 2 
the m94 allele containing mutant worms grown at 25°C. Integrated transgene expressing 3 
the orthologue protein of the p.(Arg778Trp) variant UNC-45(Arg792Trp), of the 4 
p.(Ser403Pro) variant UNC-45(Ile422Pro), and of the p.(Cys514Arg) variant UNC-5 
45(Cys532Arg) were unable to rescue the movement phenotype of the unc-45(m94) 6 
strain. Body bend/thrashing counts of young adult worms in liquid medium were only 7 
slightly improved compared to wild-type levels for the UNC-45(Arg792Trp) and UNC-8 
45(Ile422Pro) transgenes, whereas worms expressing the UNC-45(Cys532Arg) 9 
transgene were as impaired as unc-45(m94) without transgenic expression  (Figure 6A). 10 
Assessing population motility of 60 worms using an ARENA WMicrotracker (NemaMetrix) 11 
reproduced the motility defect on a solid agar surface (Figure 6C). These data suggest 12 
that the c.2332C>T; p.(Arg778Trp), the c.1207T>C; p.(Ser403Pro), and the c.1540T>C; 13 
p.(Cys514Arg) variants very likely affect UNC-45B protein function. In contrast, 14 
expressing the orthologue protein of the p.(Arg754Gln) variant UNC-45(Arg767Gln) in the 15 
unc-45(m94) background was able to rescue the defect in movement (Figure 6A and C). 16 
Although not possessing polynuclear myofibers, sarcomere organization and 17 
components in C. elegans body wall muscle cells are highly conserved: thick filaments 18 
are formed by myosin heavy chains A and B, thin filaments are formed by actin fibers, 19 
and Z-disk-equivalent dense bodies are formed by α-actinin and integrins35. Sarcomere 20 
numbers in body wall muscle cells can be assessed by established staining methods, 21 
which allow counting periodically organized sarcomeric components. In accordance with 22 
motility assays and contrary to the UNC-45(Arg767Gln) transgenic rescue, the UNC-23 
 24 
45(Arg792Trp), the UNC-45(Ile422Pro), and the UNC-45(Cys532Arg) transgenic rescues 1 
showed no improvement of the sarcomeres of the m94 ts-allele in phalloidin-staining of 2 
filamentous F-actin-containing I-bands (Figure 6D and E). 3 
Based on the known mechanistic role of the UCS domain16; 17; 34, the corresponding 4 
arginine residues in C. elegans can be precisely linked to myosin binding. Whereas 5 
FLAG-tagged UNC-45(Arg767Gln) was able to bind to the substrate myosin heavy chain 6 
B (MHC B/UNC-54) in co-immunoprecipitation experiments (Figure 6F), UNC-7 
45(Arg792Trp) was not able to pull down MHC B from worm lysates, suggesting 8 
conformational changes of the myosin binding canyon in the UCS domain for the variant 9 
protein. Conceivably, binding to C. elegans Hsp90 orthologue DAF-21 via the TPR 10 
domain was not impaired in both variant proteins. 11 
It is noteworthy however that in these transgenic rescue experiments we are not 12 
able to control for the additional hypomorphic deficiency situation of the 13 
p.(Arg754Gln)/(Arg767Gln) variant. Although the Arg767Gln transgene is expressed at a 14 
slightly lower levels than the wild-type transgene in these experiments (Figure 6F), it is 15 
still able to rescue the muscle phenotype and bind to MHC B. Reduced levels of UNC-45 16 
have been shown to be detrimental for muscle development29; 36. Our results therefore 17 
suggest, that the UNC45B p.(Arg754Gln) missense is not the primary cause of 18 
pathogenicity in those individuals, and the disease is most likely driven by the reduction 19 







We report ten individuals from eight independent families with a largely consistent clinical 2 
phenotype of early onset, slowly progressive muscle weakness manifesting with axial and 3 
proximal weakness and respiratory involvement with a muscle histotype findings including 4 
eccentric and unstructured cores as well as ultrastructual findings suggstive of an 5 
accumulations of myofibrillar material. All individuals were found to have biallelic variants 6 
in UNC45B, which encodes a highly conserved myosin-specific chaperone that is 7 
involved in assembly, function, and maintenance of type II myosin, facilitating assembly 8 
and function of striated muscle contraction. UNC-45, together with the general 9 
chaperones Hsp70 and Hsp90, forms a transient anchoring chain that organizes a 10 
properly spaced assembly line, locking the myosin head into an actin bound confirmation 11 
by facilitating hydrolysis17. This repeating unit stabilizes the thick filament and inhibits the 12 
myosin power stroke37. A single individual with myopathy who was homozygous for the 13 
c.2261G>A variant was previously reported, suggesting a tentative disease association; 14 
however, the precise interaction of UNC-45B with myosin in muscle function and disease 15 
remained poorly understood38.  16 
Early-onset myopathies are a clinical and genetic heterogeneous group of 17 
disorders of variable severity in which approximately half of individuals do not have a 18 
confirmed genetic etiology39; 40. Significant extraocular and facial weakness were notably 19 
absent in the UNC45B individuals reported here, which is in contrast to the core 20 
myopathies due to pathogenic variants in RYR1 (MIM: 180901), CACNA1S (MIM: 21 
114208), or SPEG (MIM: 615950) in which involvement of the extraocular and facial 22 
muscles are typically seen41-43. Of the ten individuals reported here, tachycardia was 23 
noted in two, while two individuals presented with structural cardiac changes (VSD and 24 
 26 
aortic coarctation). UNC-45B is highly expressed in human cardiac tissue and has an 1 
important evolutionary role in cardiac contractility28; 44; 45. Thus, the lack of more significant 2 
functional cardiac involvement in our cohort is noteworthy; however, it remains unclear 3 
whether a more severe cardiac phenotype might evolve over time.  4 
Pathogenic variants in various myosin chains including MYH2 (MIM: 160740) and 5 
MYH7 (MIM: 160760) are a known cause of myopathies of variable severities, with clinical 6 
and histological findings similar to our UNC45B individuals46; 47. Various genetically 7 
defined core myopathies with clinical overlap, including RYR1 and MYH7-related 8 
myopathies can present with a characteristic and recognizable pattern of muscle 9 
involvement and sparing when assessed by muscle imaging48-50. A selective and 10 
potentially diagnostic pattern of muscle involvement, however, was thus far not evident 11 
on muscle imaging in our UNC45B cohort. Instead, imaging revealed a fairly uniform 12 
involvement of all muscles with a possible hint of relative sparing of the 13 
semimembranosus muscle of the hamstring group. In contrast to a dystrophic process, 14 
which is characterized by uniform fatty infiltration, or to a neurogenic process in which we 15 
typically see a coarse “moth-eaten” appearance on MRI, the muscle of UNC45B 16 
individuals had a characteristic “marbled-like” appearance on fat sensitive T1 MRI 17 
sequences, which could potentially be a characteristic and thus diagnostically helpful 18 
finding49. Given the potential developmental role of UNC-45B14; 15, it is of note that the 19 
myofibrillar apparatus in the individuals reported here appears to be normal at baseline 20 
with normal in vitro contractile performance and myosin cross bridge cycling. Therefore, 21 
we hypothesize that with ongoing use and stress on the muscle fibers over time, the 22 
sarcomere is inadequately maintained due to reduction in myosin chaperone availability 23 
 27 
and/or functioning. Repair capacity may be overloaded, and sarcomeres start 1 
disintegrating, thereby giving rise to the unstructured cores and the accumulation of Z-2 
line/myofibrillar material consistently seen in the UNC-45B muscle biopsies. 3 
Consistent with an abnormal function of UNC-45B in relation to the sarcomere, 4 
muscle immunofluorescence findings performed in three biopsies reveal abnormal 5 
localization of the residual UNC-45B protein away from the M-line centered A-band where 6 
the myosin heads are located in need of maintenance and repair, instead accumulating 7 
in the Z-disc region (Figure 3A and B). In zebrafish it has been shown that the Z-line holds 8 
a “reservoir” of UNC-45B which shuttles to the myosin-containing A-band of the muscle 9 
sarcomere in response to eccentric exercise or induced damage to the myofiber51; 52. This 10 
abnormal localization was observed in all three analyzed samples and thus seems to be 11 
independent of the underlying variant and UNC-45B domain impacted. Even though a 12 
biopsy provides only a static image, the abnormal localization is consistent with the 13 
assumption that the dynamic shuttling process might be impaired as well. Lack of proper 14 
UNC-45B localization and function under conditions of continued sarcomere use and 15 
stress could then conceivably lead to the multifocal disruption and ultimate disarray of the 16 
myofibrillar apparatus, corresponding to the histologic and ultrastructural findings of 17 
eccentric and unstructured cores seen in our affected individuals. This might also help 18 
explain why the myopathic phenotype seen in UNC45B-related disease shows a 19 
progressive course, distinct from the typical more static clinical course of congenital 20 
myopathies. Further in vitro testing will be required to determine whether the mislocalized 21 
UNC-45B observed in affected individual’s muscle impairs the recurring myosin cross 22 
bridge cycling needed for repeated contraction. 23 
 28 
Previous work on the highly conserved UNC-45 in various models including C. 1 
elegans, zebrafish and mouse, has shown that loss of UNC-45 is embryonically lethal29; 2 
30; 53. In this context it is notable that we have not observed individuals with biallelic null 3 
variants, and no homozygous null variants are listed in GnomAD, suggesting that this 4 
situation in the human may also be either not tolerated or be associated with a 5 
considerably more severe phenotype. We have shown that the recurring c.2261G>A 6 
variant is a complex splice allele, that creates a hypomorph scenario, with the residual 7 
protein containing the p.(Arg754Gln) variant. This conclusion is supported by analysis of 8 
available UNC-45B muscle biopsies, as all analyzed samples had a reduction in UNC-9 
45B protein by western blot, which was most significant in the homozygous c.2261G>A 10 
biopsy (Figure 4C). Thus, we suspect that the disease mechanisms for this variant are 11 
largely driven by the protein deficiency, with additional contribution from a functionally 12 
impaired residual protein. Recombinant UNC-45B(Arg754Gln) variant protein indeed 13 
exhibited a lower melting temperature in thermal shift assays and aggregation tendency 14 
(Figure 5D and E). On the other hand, the ability of the corresponding C. elegans variant 15 
UNC-45(Arg767Gln) to rescue a temperature-sensitive mutant allele in transgenic rescue 16 
assays corroborates the notion, that the reduction in overall protein amount is the cause 17 
for the disease phenotype rather than the missense and possibly impaired residual 18 
protein itself (Figure 6). 19 
In supplemental C. elegans biochemical assays, no changes in UNC-45 20 
ubiquitylation were detected (Figure S4C), although both UCS domain missense variants 21 
were slightly more susceptible to trypsin proteolysis (Figure S4D and E). The UNC-45B 22 
transgenes of p.(Arg778Trp) (C. elegans Arg792Trp), of p.(Ser403Pro) (C. elegans 23 
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Ile422Pro), and of p.(Cys514Arg) (C. elegans Cys532Arg) were found to have a more 1 
detrimental effect on function, with an inadequate rescue of the paralyzed phenotype and 2 
impaired binding to myosin for p.(Arg778Trp). These more severe and obvious functional 3 
consequences in the C. elegans rescue assay are consistent with the fact that the variants 4 
cause disease in the human situation. Therefore, we propose that UNC45B variants 5 
impact UNC-45B chaperone activity through reduction in overall protein levels 6 
(c.2261G>A), impaired normal myosin-binding (c.2332C>T; p.Arg778Trp), or a 7 
combination of both.   8 
UNC45B-related disease can be classified as both a chaperonopathy resulting in 9 
a secondary myosinopathy as well as a myofibrillar dystrophy, given the progressive 10 
disintegration of the myofibrillar apparatus. The continued dissolution of the myofibrillar 11 
structure which clinically manifests as progressive muscle weakness is characteristic of 12 
the chaperone dysfunction in forms of childhood onset dystrophy8. Pathologically, this 13 
disorder could be considered a myofibrillar dystrophy, as the excessive nuclear 14 
centralization seen on histology is a marker of an activated regenerative process. This is 15 
in contrast to a sarcolemmal dystrophic process, which typically leads to a more 16 
inflammatory and fibrotic picture, leading to excessive matrix and fat proliferation. In 17 
UNC45B-related disease we suspect a “dystrophic process internal to the myofiber” 18 
causing fibers to disappear focally with less of matrix reaction, hence the marbled 19 
appearance on muscle MRI. Biallelic variants in UNC45B should therefore be considered 20 
in individuals presenting with a myopathy specifically in the presence of core histology 21 
and ultrastructural findings including cytoplasmic bodies, rods and autophagic lesions. 22 
Additional research is needed to further elucidate the exact pathogenic UNC45B-related 23 
 30 
disease mechanism and to find therapeutic strategies aimed towards restoring 1 
sarcomeric homeostasis through modulating chaperone activity. This has shown great 2 
promise for neurodegenerative disorders, with specific interest in the finding that 3 
overexpression of UNC-45 in a Drosophila model of Huntington-induced cardiac 4 
amyloidosis resulted in reduced poly-glutamine aggregation and myofibrillar 5 
disorganization54. Taken together, our data solidifies the role of UNC-45B as a key 6 
regulator of myofibril maintenance and function, a tightly regulated pathway that is 7 
conserved from human to yeast, with impaired UNC-45B function resulting in 8 
recognizable muscle pathology clinically manifesting with myopathy. 9 
 10 
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Figure Titles and Legends 9 
Figure 1. Biallelic variants in the myosin-directed chaperone UNC-45B.  (A) UNC-45 10 
contains four domains: an N-terminal TPR domain (light green), a conserved central 11 
domain (dark grey), a neck domain (light grey), and a C-terminal UCS domain (orange). 12 
The N-terminal TPR domain is important for the interaction with Hsp90 and Hsp70 13 
chaperones, and the C-terminal UCS domain binds directly to the myosin head domain. 14 
The recurring UNC45B variant p.Arg754Gln (dark blue) and the p.Arg778Trp (light blue) 15 
variant impact conserved arginines in the myosin-binding UCS domain. Variants 16 
p.Ser403Pro (pink) and p.Cys514Arg (dark green) are located in the UNC-45B neck 17 
domain. (B) Overview of the muscle sarcomere. UNC-45 is involved in myofibrillogenesis 18 
cooperating with Hsp90 to fold and to incorporate myosin into the thick filament. In 19 
adulthood UNC-45 is stored at the Z-disk. Upon injury to the muscle fiber, UNC-45 20 
shuttles to the A-band to help refold damaged myosin. 21 
 22 
Figure 2. Muscle MRI and histological findings in individuals with UNC45B-related 23 
myopathy. (A)  Lower extremity muscle MR imaging was available for five (P1-P5) 24 
individuals and showed mild, fat infiltration evident in all lower extremity muscles resulting 25 
in a marbled-like appearance. In individuals P1, P4, and P5 there is abnormal (increased) 26 
T1 signal without an apparent pattern of muscle involvement except for relative sparing 27 
 37 
of the semimembranosus muscle in individuals P1 and P5.  P1 and P3 had evidence of 1 
mild, generalized muscle atrophy, while in P2, P4 and P5 muscle bulk appeared normal 2 
(B-K). UNC45B-related myopathy manifests histologically with unstructured cores. On 3 
histological analyses there are findings of: (B) increased internalized nuclei with 4 
numerous multinucleated fibers seen on H&E staining (P1); (C) uneven deposits of 5 
fuchsinophilic material is seen on GT staining (P4); (D) core-like regions often located 6 
along the periphery of fibers and consistent with eccentric cores are seen on SDH staining 7 
(P3); (E) areas of increased staining along the periphery of fibers with decreased staining 8 
centrally is seen on NADH staining (P6); and (F) large irregular areas of decreased 9 
staining seen on COX staining (P4). On EM there are findings of: (G) myofibrillar disarray 10 
(P3); (H) diffusion of Z-line material (P4); (I) autophagy lesions (P3); (J) wide bands of 11 
diffusion of the Z-line material which have spread in the disorganized areas (P3); and (K) 12 
a cytoplasmic body (P4). White scale bar corresponds to 50 µm, orange scale bar 13 
corresponds to 5 µm. 14 
 15 
Figure 3. Misclocalized UNC-45B in affected individual’s muscle. (A) Longitudinal 16 
sections of muscle biopsies of control and P1, P9, and P10 stained for UNC-45B (red) 17 
and M-line protein myomesin (green) (top row). UNC-45B is reduced in the M-line and 18 
mislocalized from the A-band, around the M-line, to the Z-disc in these three individuals 19 
compared to control. Overlay of intensity profile of UNC-45B and myomesin (bottom 20 
row) from the cropped area (middle row) shows mislocalization of UNC-45B away from 21 
the A-band to the Z-disk. (B)  Longitudinal sections of muscle biopsies of control and P1 22 
stained for UNC-45B (red) and Z-disk protein α-actinin (green) revealing colocalization 23 
 38 
of UNC-45B at the Z-line. Overlay of intensity profile of UNC-45B and α-actinin in P1 1 
from the cropped area (middle row) shows loss of co-location of UNC-45B with the M-2 
line.  3 
 4 
Figure 4. UNC45B variant c.2261G>A creates a complex hypomorph splice variant. 5 
(A) The last base pair of exon 17 in UNC45B c.2261G, orange) is adjacent to the splice 6 
donor site of intron 17 (bold black). The c.2261G>A transition, located in the exonic part 7 
of the 5’ recognition sequence (G-▼-G-U-G-A-G-U), leads to the activation of a nearby 8 
cryptic splice donor site (blue). The resulting spliced mRNA transcript is elongated by 9 9 
additional bases including an in-frame STOP codon (blue frame). (B) Schematics of 10 
normal UNC45B exon 17–18 splicing (1) and of the two splice products seen in UNC45B 11 
c.2261G>A muscle: (2) full length product including the Arg754Gln substitution and (3) 12 
activation of the nearby cryptic splice donor site generating an elongated splice product 13 
that includes an in-frame STOP codon. (C) Western blot analysis of UNC-45B in muscle 14 
extracts from P1, P2, P9, and P10 compared to control. Quantification shows a significant 15 
reduction of UNC-45B in P1, P2, P9, while levels in P10 were slightly reduced. Mouse 16 
monoclonal anti-desmin was used as a loading control.  17 
 18 
Figure 5. UNC-45B mutant proteins are prone to aggregation. A) Structure of human 19 
UNC-45B based on the C. elegans UNC-45 3D structure (PDB ID: 4i2z)17. The recurring 20 
p.(Arg754Gln) (dark blue) and the p.(Arg778Trp) (P2) UNC45B variant (light blue) impact 21 
conserved arginine residues in the myosin binding UCS domain (orange) and can be 22 
precisely mapped to helices 1 and 3, respectively, in the armadillo (ARM) repeat 14. ARM 23 
 39 
14 is located in the hinge region, which connects the C-terminal half of the UCS domain 1 
(ARM repeats 14–17) with the N-terminal half (ARM repeats 10–13) and forms part of the 2 
myosin-binding canyon. The p.(Ser403Pro) (pink, P9) and p.(Cys514Arg) (dark green, 3 
P10) variant impact the UNC-45B neck domain. the structure of the human UNC-45B 4 
protein was inferred from the C. elegans UNC-45 structure17 (PDB ID: 4i2z) using Swiss-5 
Model21 and corresponding residues were mutated in PyMOL to display the reported 6 
variants. Van der Waals overlaps of the newly incorporated amino acid residues with the 7 
unmodified protein structure are depicted as red disks. (B) Purified UNC-45BWT, UNC-8 
45BArg754Gln, UNC-45BArg778Trp, UNC-45BSer403Pro, and UNC-45BCys514Arg buffered solutions 9 
were subjected to partial proteolysis with trypsin at 37°C and samples were loaded on 10 
SDS-PAGE gels for separation. Coomassie-stained gels of one of two repetitions are 11 
shown. (C) Quantification of full-length protein (FL, ~109 kDa) compared to time point 0 12 
at 37°C of two repetitions. Mean and SD can be found in  Table S4. (D) Purified UNC-13 
45BWT, UNC-45BArg754Gln, UNC-45BArg778Trp, UNC-45BSer403Pro, and UNC-45BCys514Arg 14 
buffered solutions were slowly heated from 10°C to 95°C in the presence of SYPRO 15 
Orange protein stain. Boltzmann sigmoidal curves were fit to normalized combined melt 16 
curves of three experiments. Half maximal temperatures indicate melting temperatures in 17 
the Tris-based buffer. Mean and SD can be found in Table S5 (E) Slot blot of purified 18 
UNC-45BWT, UNC-45BArg754Gln, UNC-45BArg778Trp, UNC-45BSer403Pro, and UNC-19 
45BCys514Arg Tris-buffered solutions incubated for 1 h at room temperature filtered through 20 
a 0.2 µm acetyl-cellulose membrane. Three decreasing amounts of protein solution were 21 
blotted for comparison. (F) Baseline-subtracted SYPRO fluorescence values at 22°C 22 
obtained in two experiments in (D) are plotted for each protein solution. No significant 23 
 40 
differences between WT and mutant proteins were found in non-parametric Kruskal-1 
Wallis test. 2 
 3 
Figure 6.  Various missense UNC-45 mutant proteins cannot rescue a conditional 4 
loss-of-function allele. Transgenic UNC-45Arg792Trp mutant protein is unable to rescue 5 
the motility defect of unc-45(m94) worms grown at the restrictive temperature of 25°C, 6 
whereas UNC-45Arg767Gln rescues the m94 motility defect. (A) Body bends of 30 young 7 
adult unc-45(m94) worms expressing the indicated UNC-45 variants were counted in at 8 
least three different experiments. Values are mean ± SEM; *: p<0.0001 compared to 9 
control in non-parametric Kruskal-Wallis test. (B) Expression levels of UNC-45-FLAG 10 
transgenes in young adult unc-45(m94) worms. (C) Population motility of 60 young adult 11 
unc-45(m94) worms expressing the indicated UNC-45 variants on a 24 well plate filled 12 
with NGM and seeded with OP50 was measured with the ARENA WMicrotracker system 13 
(NemaMetrix) at 25°C for 24 hours after reaching adulthood. (D) Phalloidin-staining of F-14 
actin-containing I-bands in unc-45(m94) mutant worms expressing the indicated UNC-45 15 
variants. (E) The number of I-bands is given per body wall muscle cell (indicated by 16 
dashed white line in D), with all 12 analyzed cells located in the same area between 17 
pharynx and vulva. Values are mean ± SEM; *: p<0.005 compared to control in non-18 
parametric Kruskal-Wallis test. (F) Co-immunoprecipitation of myosin heavy chain B 19 
(MHC B) and Hsp90 (DAF-21) from cell lysates of unc-45(m94) mutant worms expressing 20 
the indicated FLAG-tagged UNC-45 variants grown at 25°C. Representative result of one 21 
of three experiments is shown. 22 
 23 
 41 
Table Title and Legend 1 
Table 1. Clinical characteristics and UNC45B variants identified. CK, creatine kinase; 2 
ECG, electrocardiogram; EM, electron microscopy; EMG, electromyography; F, female; 3 
FVC, forced vital capacity; IVC,  inferior vena cava; m, maternal; M, male; mo, months; 4 
NA, not available; NADH, Nicotinamide adenine dinucleotide; p, paternal; R, right; s/p, 5 
status post;  VSD, ventricular septal defect; yrs, years.  6 
 42 
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Ankle 
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prominent 
calcaneus. 
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ophthalmoplegia, 
joint 
hypermobility, 
premature 
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